Lathrop Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Lathrop Investment Management's BMY Position: Q2 2026 in Review
Lathrop Investment Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 4,601 shares worth $265K. The position accounts for 0.05% of the portfolio, ranked #81.
Lathrop Investment Management first reported a position in BMY in Q1 2020 and has held it in 23 quarters since. The position peaked at $393K in Q2 2022. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Lathrop Investment Management held 4,601 shares of Bristol-Myers Squibb worth $265K as of Q2 2026.
- Lathrop Investment Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.05% of Lathrop Investment Management's portfolio in Q2 2026, its #81 holding.
- Lathrop Investment Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 23 quarters since.
- Lathrop Investment Management's Bristol-Myers Squibb position peaked at $393K in Q2 2022.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Lathrop Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.